ArticleBritish journal of clinical pharmacology2026
Quality indicators for safe and effective medication use in long-term care facilities: A modified Delphi study.
Article in British journal of clinical pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quality indicators for safe and effective medication use in long-term care facilities: A modified Delphi study.British journal of clinical pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
aimThis modified Delphi study aimed to achieve expert agreement on quality indicators (QIs) suitable for application at the population level, to evaluate quality use of medications and pharmacist services in long-term care facilities (LTCFs).
methodsWe conducted a two-round modified online Delphi study with a multidisciplinary panel of Australian subject matter experts (n = 25). Experts rated 58 QIs, identified in a recent systematic review, on three criteria (importance, feasibility and amenability to change by an on-site pharmacist) using a 9-point Likert scale. A QI was selected if it reached agreement between expert members (defined as a disagreement index of ≤1) with a high median score (≥7 on the Likert scale) across all three criteria.
resultsTwenty-five experts completed the first Delphi round, and 24 completed the second round. Overall, high scores with agreement were obtained for 45 QIs (78%) for importance, 27 QIs (47%) for feasibility and 25 QIs (43%) for amenability to change. Seventeen of the 58 QIs received high scores in agreement across all three criteria and were selected, covering: multidisciplinary clinical care (n = 7 QIs), clinical governance (n = 5), medication-specific issues (n = 3) and end-of-life care (n = 2).
conclusionThe identified QIs provide a valuable foundation to capture and monitor the complexity of medication management, including on-site pharmacist services, in LTCFs. Subject to future testing and research, the expert-prioritized QIs could help optimize medication-related quality of care efforts and improve outcomes for residents in LTCFs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.